comparemela.com

Latest Breaking News On - Mindy valcarcel - Page 4 : comparemela.com

FDA grants Retevmo accelerated approval for pediatric patients with thyroid cancer

FDA grants Retevmo accelerated approval for pediatric patients with thyroid cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

mRNA vaccine reprograms immune system to attack glioblastoma

An mRNA cancer vaccine developed at University of Florida may have the ability to reprogram the immune system against glioblastoma, findings of a first-in-human trial showed.The trial — results of which appeared in Cell— included four adults with immunotherapy-resistant MGMT unmethylated glioblastoma.

Zanidatamab induces response in refractory HER2-positive biliary tract cancer

Zanidatamab induces response in refractory HER2-positive biliary tract cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Invisible ink for radiation may improve patient quality of life

A novel invisible ink tattoo technique may improve long-term quality of life and emotional well-being for people with cancer who undergo radiation therapy, according to study results.Radiation setup typically involves marking treatment areas with permanent black or blue tattoo ink to ensure correct alignment of the radiation machine over the weeks-long duration of treatment.

American Cancer Society awards $28M in grants

American Cancer Society has awarded $28 million in new extramural discovery science research and career development grants to fund investigators across several U.S. institutions beginning in July 2024. “We are very proud to announce these new grant awardees and their critically important research projects,” Christina Annunziata, MD, PhD, senior vice president of extramural discovery

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.